Blogs
Stay current with product and data science updates, industry and technology trends, and culture updates from the CancerLinQ team.
How Owkin and CancerLinQ aim to improve lung cancer treatment using federated learning
CancerLinQ and Owkin announced a new research collaboration to work together to use artificial intelligence to understand the treatment of non-small…
Updated July 7, 2022: Demographics of Patients with Cancer and COVID-19 Disease
CancerLinQ Data
Patients with cancer and COVID-19 constitute those with a cancer diagnosis who fit at least one of the
following three criteria:
following three criteria:
CancerLinQ Discovery Improves Understanding of Clinical Trial Enrollment and Prostate Cancer Survival
By: Thomas Flaig, MD
It was so great to be back in person for this year’s ASCO Annual Meeting to see many long-time colleagues and meet a few new ones as well.
Updated June 3, 2022: Demographics of Patients with Cancer and COVID-19 Disease
CancerLinQ Data
Patients with cancer and COVID-19 constitute those with a cancer diagnosis who fit at least one of the following three criteria:
How CancerLinQ is Helping Improve Care in New England One Data Field at a Time
Dawn Whitten, Director of Clinical Informatics and Information Technology New England Cancer Specialists
Have you ever noticed how small adjustments like streamlining meetings or moving your commute outside of rush hour can improve your life and work?…
EMPLOYEE SPOTLIGHT: Nehanda Jones
Nehanda Jones is a Real-World Evidence Scientist with CancerLinQ. In her role as a Scientist and Subject Matter Expert (SME), her focus is giving our…
Updated May 3, 2022: Demographics of Patients with Cancer and COVID-19 Disease
CancerLinQ Data
Patients with cancer and COVID-19 constitute those with a cancer diagnosis who fit at least one of the following three criteria:
CancerLinQ/Count Me In Collaboration Will Allow More Patients to Contribute to Research
By: Nikhil Wagle, MD
Clinical trials have historically been the main way of improving our understanding and treatment of cancer, but less than 5 percent of patients…
Electronic Quality Measures Video Podcast
JCO CCI
In this interview, Dr. Anna Schorer and Dr. Richard Moldwin from the CancerLinQ Oncology Informatics Task Force discuss their article "Chasm…
